10x Genomics
TXG
$40.49
Share price
-1.84%
Change (1 day)
-4.50%
Change (1 year)
Categories
Earnings for 10x Genomics (TXG)
Earnings in 2023 (TTM): -$0.17 B
According to 10x Genomics 's latest financial reports the company's current earnings (TTM) are -$0.17 B. In 2022 the company made an earning of -$0.17 B a decrease over its 2021 earnings that were of -$53.72 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for 10x Genomics from 2019 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.17 B | 3.02% |
| 2022 | -$0.17 B | 201.54% |
| 2021 | -$53.72 M | -89.95% |
| 2020 | -$0.54 B | 1622.28% |
| 2019 | -$31.04 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -$18.07 M | -89.17% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $56.65 M | -133.95% | 🇬🇧 UK |
 Novavax NVAX | -$0.57 B | 241.17% | 🇺🇸 USA |
 Novocure
NVCR | -$0.2 B | 14.16% | Jersey |